|
|
| (One intermediate revision by one other user not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Doxazosin#How Supplied]] |
| {{Doxazosin}}
| |
| {{CMG}}; {{AE}} {{AK}}
| |
| | |
| ==HOW SUPPLIED==
| |
| | |
| Doxazosin Tablets, USP are available as white to off-white tablets for oral administration. Each tablet contains doxazosin mesylate equivalent to 1 mg, 2 mg, 4 mg or 8 mg of the active constituent, doxazosin.
| |
| | |
| Doxazosin Tablets, USP are available as 1 mg (white to off-white, round, scored tablets, imprinted “APO” on one side and “093” with a partial bisect on the other side), 2 mg (white to off-white, capsule shaped, scored tablets, imprinted “APO” on one side and “094” with a partial bisect on the other side), 4 mg (white to off-white, capsule shaped, scored tablets, imprinted “APO” on one side and “095” with a partial bisect on the other side) and 8 mg (white to off-white, capsule shaped, scored tablets, imprinted “APO” on one side and “096” with a partial bisect on the other side).
| |
| | |
| Bottles of 100:
| |
| | |
| 1 mg (NDC 60505-0093-0)
| |
| | |
| 2 mg (NDC 60505-0094-0)
| |
| | |
| 4 mg (NDC 60505-0095-0)
| |
| | |
| 8 mg (NDC 60505-0096-0)
| |
| | |
| Bottles of 1,000:
| |
| | |
| 1 mg (NDC 60505-0093-1)
| |
| | |
| 2 mg (NDC 60505-0094-1)
| |
| | |
| 4 mg (NDC 60505-0095-1)
| |
| | |
| 8 mg (NDC 60505-0096-1)
| |
| | |
| Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
| |
| | |
| Dispense in a tight, light-resistant container [see USP].
| |
| | |
| '''APOTEX INC.
| |
| | |
| DOXAZOSIN TABLETS, USP
| |
| | |
| 1 mg, 2 mg, 4 mg and 8 mg'''
| |
| | |
| [[image:doxa7.png]]
| |
| <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = DOXAZOSIN TABLET [APOTEX CORP.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4fa5c2f7-cda9-56cd-622f-b3d05dc7c94b | publisher = | date = | accessdate = 7 March 2014 }}</ref>
| |
| | |
| | |
| | |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |